CrowdPharm Named a 2023 PM360 Pharma Choice Award Winner


KANSAS CITY, MO— February 1, 2023 – CrowdPharm, a full-service agency whose proprietary technology fuels one of the largest global healthcare talent networks anywhere, announced today that PM360, a leading trade magazine for marketing-decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named, CrowdPharm as a MultiChannel Pharma Choice Silver winner.

Since 2009, the PM360 Pharma Choice awards have served as the only industry awards to recognize outstanding achievement and creativity in healthcare and life sciences marketing by allowing the industry to choose the winners. All submissions are placed online where anyone in the industry can vote for their favorites based on content, format, imagination, influence on the industry, impact on the audience, and overall quality. This year, more than 8,500 votes were cast to decide the winners.

“The best critics are the people who understand your circumstances, challenges, and ultimately what it takes to be successful. In life sciences marketing, that description can only apply to other life sciences marketers, which is why we give each and every marketer in this industry the opportunity to decide what can be called the best campaigns of the year,” said Anna Stashower, CEO/Publisher/Editor-in-Chief, PM360.

“It is also what makes winning one of our Pharma Choice Awards so significant because it is an honor bestowed upon marketers by their peers—the only people who truly can comprehend just how hard it is to be creative, imaginative, engaging, captivating, and memorable in a highly regulated industry. These winning campaigns and initiatives didn’t just leave an impression on their intended audience but on the people in the industry responsible for creating them day in and day out.”

In total, 42 winners were named in 14 distinct categories: App, Consumer Website, DTC/DTP, Multichannel, Multicultural, Philanthropic, Professional Print Campaign, Professional Website, Sales Aid, Self-promotion/Corporate Campaign, Social Media, Unbranded, Variety, and Video. A Gold, Silver, and Bronze award is given to the entries that receive the top three most in each category.

The winning work is featured in the January/February 2023 issue of PM360. And can be viewed online at

About CrowdPharm
CrowdPharm is an independent full-service agency led by industry veterans and fueled by one of the largest networks of global talent anywhere. The agency’s innovative approach, supported by their proprietary technology platform, delivers an abundance of original strategic and creative solutions across time zones, and provides a flexible force of talent with experience that spans startups, orphan products, blockbusters, and primary care. With 5,800+ members from 118+ countries, CrowdPharm is ready to develop compelling brand communications in healthcare, medical, and pharmaceutical marketing for pharmaceutical and biopharma companies. Visit

About PM360
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment. The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read. By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.

More posts
New Artist-Protecting Technology Helps Fight Against Copyright Violation
Read more >
CrowdPharm's Work in AI Is Named by PM360 as One of the Most Interesting Innovations of 2023
Read more >
CrowdPharm Named MM+M Best Places to Work 2023
Read more >
See more